Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
- PMID: 19370608
- DOI: 10.1002/14651858.CD004753.pub3
Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
Update in
-
Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.Cochrane Database Syst Rev. 2017 Jan 23;1(1):CD004753. doi: 10.1002/14651858.CD004753.pub4. Cochrane Database Syst Rev. 2017. PMID: 28114727 Free PMC article.
Abstract
Background: Endometriosis is a common gynaecological condition that affects women and can lead to painful symptoms and infertility. It greatly affects women's quality of life, impacting on their careers, everyday activities, sexual and non-sexual relationships, and fertility. Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly used first-line treatment for endometriosis.
Objectives: To assess the effects of NSAIDs used for the management of pain in women with endometriosis compared to placebo, other NSAIDs, other pain management drugs, or no treatment.
Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Trials Register (April 2008) published in the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), MEDLINE (1966 to April 2008), EMBASE (1980 to April 2008), and the reference lists from relevant publications. Experts in the field were also contacted for information about possible studies.
Selection criteria: We included all randomized controlled trials (RCTs) describing the use of NSAIDs in the treatment of endometriosis in women of all ages.
Data collection and analysis: Two review authors (CA and SH) independently read and extracted data from each of the included studies. Crossover trials were analysed using the inverse variance method in RevMan to calculate the odds ratio for binary outcomes.
Main results: Two trials were identified but only one trial, with 24 women, was included in the analysis. Comparing NSAIDs (naproxen) to placebo, there was no evidence of a positive effect on pain relief (odds ratio (OR) 3.27, 95% CI 0.61 to 17.69) in women with endometriosis. There was also inconclusive evidence to indicate whether women taking NSAIDs (naproxen) were less likely to require additional analgesia (OR 0.12, 95% CI 0.01 to 1.29) or to experience side effects (OR 0.46, 95% CI 0.09 to 2.47) when compared to placebo.
Authors' conclusions: There is inconclusive evidence to show whether or not NSAIDs (naproxen) are effective in managing pain caused by endometriosis. There is no evidence on whether any individual NSAID is more effective than another. As shown in other Cochrane reviews, women using NSAIDs need to be aware of the possibility that these drugs may cause unintended effects.
Update of
-
Non-steroidal anti-inflammatory drugs for pain in women with endometriosis.Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004753. doi: 10.1002/14651858.CD004753.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004753. doi: 10.1002/14651858.CD004753.pub3. PMID: 16235379 Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous